Dobutamine Injection, Solution, Concentrate
Product Images NDC 51662-1337

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Dobutamine (NDC 51662-1337). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51662 1337 2 Pouch Labeling

Label for Dobutamine Injection, USP 250 mg per 20 mL (12.5 mg/mL) in a 20 mL vial. The label includes lot and expiration details, usage instructions indicating dilution prior to intravenous use, and storage conditions. Manufactured by HF Acquisition Co LLC, DBA HealthFirst, and includes a barcode and references to the original manufacturer NDC.*

FDA Label Image

51662 1337 3 Case Labeling

DOBUTAMINE Injection, USP 250 mg per 20 mL (12.5 mg/mL) vial label on a case of 10. The label indicates intravenous use, must be diluted prior to use, and provides storage instructions and ingredient information. Manufactured by HF Acquisition Co LLC in Mukilteo, WA.*

FDA Label Image

Dosage 1 (Dosage 1)

A data table showing infusion delivery rates for Dobutamine injection solution concentrate. It lists drug delivery rates in mcg/kg/min alongside corresponding infusion delivery rates in mL/kg/min for three concentrations: 250 mcg/mL, 500 mcg/mL, and 1,000 mcg/mL, with footnotes explaining the diluent concentrations.*

FDA Label Image

Dosage 2 (Dosage 2)

Data tables showing Dobutamine infusion rates (mL/h) for three concentrations (500 mcg/mL, 1000 mcg/mL, and 2000 mcg/mL) relative to patient body weight (30 to 110 kg) and drug delivery rate (2.5 to 15 mcg/kg/min). Each table correlates infusion rates with varying body weights and delivery rates.*

FDA Label Image

How Supplied (How Supplied)

A data table listing packaging options for Dobutamine injection, solution, concentrate. It shows units of sale (carton of 1, tray of 10), concentrations (250 mg/20 mL or 12.5 mg/mL), and individual package descriptions (20 mL single-dose vials) with corresponding NDC numbers.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Label (Serialized Vial)

DOBUTamine injection USP solution concentrate in a 20 mL single-dose fliptop vial. The vial label shows 250 mg per 20 mL and states it must be diluted prior to use for intravenous administration only. Distributed by HF Acquisition Co., LLC and manufactured by Hospira, Inc.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of dobutamine hydrochloride, showing its aromatic rings and functional groups as part of the molecule.*

FDA Label Image

Vial Label (Vial Label)

DOBUTamine Injection, USP 250 mg/20 mL (12.5 mg/mL) solution in a 20 mL single-dose fliptop vial. The label states it must be diluted prior to use and is for intravenous use only. Distributed by Hospira, Inc. The label includes concentration details and usage instructions advising use within 24 hours after dilution.*

FDA Label Image

Rfid

A small white label featuring a Data Matrix barcode and text including identification numbers. The label states distribution by HF Acquisition Co., LLC, Mukilteo, WA 98275. The label includes a note to see the manufacturer's package insert and an Rx only designation. No product name or medication details are visible on this label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.